Picosecond 532-nm neodymium-doped yttrium aluminium garnet laser—a novel and promising modality for the treatment of café-au-lait macules

Ofir Artzi, Joseph N. Mehrabi, Amir Koren, Roni Niv, Moshe Lapidoth, Assi Levi

Research output: Contribution to journalArticlepeer-review

Abstract

Café-au-lait macules (CALMs) present as benign hyperpigmented, well-circumscribed spots on the skin for which many patients seek treatment for aesthetic reasons. The objective of this study is to report our experience in treating CALMs using a picosecond 532-nm neodymium-doped yttrium aluminium garnet (PS 532 nm) laser. This is a retrospective case series of 16 patients with CALMs who were treated by a PS 532-nm laser (1–4 treatments, 4–8 weeks apart). Response as seen on clinical photographs was assessed by two independent dermatologists and graded on a scale of 0 (exacerbation) to 5 (95–100% improvement). Patient satisfaction and tolerance were documented at final visit. The results of 15 patients demonstrated significant improvement (average 3.43), and their satisfaction and tolerance levels were high. One patient had no response whatsoever to treatment. The PS 532-nm laser is a promising novel modality for the treatment of CALMs.

Original languageEnglish
Pages (from-to)693-697
Number of pages5
JournalLasers in Medical Science
Volume33
Issue number4
DOIs
StatePublished - 1 May 2018

Keywords

  • Aesthetic improvement
  • Café au lait macules
  • Laser treatment
  • Picosecond 532-nm laser

Fingerprint

Dive into the research topics of 'Picosecond 532-nm neodymium-doped yttrium aluminium garnet laser—a novel and promising modality for the treatment of café-au-lait macules'. Together they form a unique fingerprint.

Cite this